Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients.

AIMS To investigate the relationship between microalbuminuria (MAU) and atrial fibrillation (AF) and to further evaluate whether the heart rate dependency of MAU in patients without AF is maintained in patients with a history of AF. METHODS AND RESULTS The International Survey Evaluating Microalbuminuria Routinely by Cardiologists in patients with Hypertension (I-SEARCH) included 18,900 patients without and 1705 patients with a history of AF suffering from hypertension and other risk factors for cardiovascular disease in 26 countries worldwide from September 2005 to March 2006. Heart rate, blood pressure, urinary albumin excretion, and an estimated glomerular filtration rate were determined among other parameters. The prevalence of MAU was higher at higher heart rate in both patients with and without a history of AF. Prevalence of MAU was about 10% higher in patients with a history of AF (P < 0.001). Male gender, the presence of diabetes mellitus, a higher heart rate, and a higher diastolic blood pressure were independently associated with increased odds for MAU in patients without and with a history of AF. CONCLUSION The prevalence of MAU in hypertensive patients with cardiovascular risk factors is related to heart rate and significantly higher in patients with a history of AF.

[1]  D. Mikhailidis,et al.  Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. , 2008, International journal of cardiology.

[2]  D. Wilber,et al.  Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. , 2008, Journal of the American College of Cardiology.

[3]  A. Goette,et al.  Angiotensin II Receptor Blockade Reduces Tachycardia-Induced Atrial Adhesion Molecule Expression , 2008, Circulation.

[4]  M. Böhm,et al.  Association of heart rate with microalbuminuria in cardiovascular risk patients: data from I-SEARCH , 2008, Journal of hypertension.

[5]  M. Böhm,et al.  Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study , 2007, Journal of hypertension.

[6]  Jean-Claude Tardif,et al.  Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.

[7]  M. Böhm,et al.  The role of heart rate in the development of cardiovascular disease , 2007, Clinical Research in Cardiology.

[8]  P. Vardas,et al.  Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. , 2007, The American journal of cardiology.

[9]  W. Stevenson,et al.  Management of atrial fibrillation in patients with heart failure. , 2007, Heart rhythm.

[10]  A. Hofman,et al.  Subclinical atherosclerosis and risk of atrial fibrillation: the rotterdam study. , 2007, Archives of internal medicine.

[11]  H. Parving,et al.  Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. , 2006, Kidney international.

[12]  Giuseppe Mancia,et al.  Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. , 2006, Journal of hypertension.

[13]  M. P. van den Berg,et al.  C-reactive protein and microalbuminuria are associated with atrial fibrillation. , 2005, International journal of cardiology.

[14]  F. Veglia,et al.  The REassessment of Antihypertensive Chronic Therapy (REACT) Study , 2004 .

[15]  L. Bouter,et al.  Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study. , 2004, Kidney international. Supplement.

[16]  G. Reboldi,et al.  Hypertension and microalbuminuria: the new detrimental duo , 2004, Blood pressure.

[17]  G. Mensah,et al.  Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.

[18]  L. Ruilope,et al.  Is it time to measure microalbuminuria in hypertension? , 2003, Journal of hypertension.

[19]  H. Janka,et al.  Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. , 2003, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[20]  S. Nattel,et al.  Atrial Ischemia Promotes Atrial Fibrillation in Dogs , 2003, Circulation.

[21]  P. Guéret,et al.  Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. , 2003, Diabetes care.

[22]  Maurizio Bentivoglio,et al.  Atrial Fibrillation in Hypertension: Predictors and Outcome , 2003, Hypertension.

[23]  H. Parving,et al.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.

[24]  E. Lewis,et al.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.

[25]  L. Guize,et al.  Cardiovascular Mortality in Hypertensive Men According to Presence of Associated Risk Factors , 2001, Hypertension.

[26]  K. Borch-Johnsen,et al.  Elevated Urinary Albumin Excretion Is Associated With Impaired Arterial Dilatory Capacity in Clinically Healthy Subjects , 2001, Circulation.

[27]  PhilippeLechat,et al.  Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001 .

[28]  A. Mallet,et al.  Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.

[29]  M. Schroll,et al.  Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. , 2000, Hypertension.

[30]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[31]  G. Kay,et al.  Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. , 1997, Journal of the American College of Cardiology.

[32]  R. Bigazzi,et al.  Microalbuminuria in essential hypertension. , 1997, Journal of nephrology.

[33]  M. Malik,et al.  Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. , 1996, Journal of the American College of Cardiology.

[34]  J. Jensen,et al.  Renal and systemic transvascular albumin leakage in severe atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[35]  G. Dell'omo,et al.  Microalbuminuria and endothelial dysfunction in essential hypertension , 1994, The Lancet.

[36]  R B D'Agostino,et al.  Influence of heart rate on mortality among persons with hypertension: the Framingham Study. , 1993, American heart journal.

[37]  J Ross,et al.  Influence of heart rate on mortality after acute myocardial infarction. , 1990, The American journal of cardiology.

[38]  K. Borch-Johnsen,et al.  Albuminuria reflects widespread vascular damage , 1989, Diabetologia.

[39]  S. Blair,et al.  Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. , 1985, American heart journal.

[40]  M. Schroll,et al.  Risk factors of myocardial infarction and death in men aged 50 at entry. A ten-year prospective study from the Glostrup population studies. , 1977, Danish medical bulletin.

[41]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[42]  J. Mitchell,et al.  HEMODYNAMIC CONSEQUENCES OF ATRIAL FIBRILLATION AT CONSTANT VENTRICULAR RATES. , 1964, The American journal of medicine.

[43]  R. Levy,et al.  Transient tachycardia; prognostic significance alone and in association with transient hypertension. , 1945, The Medical press of Egypt.

[44]  J T Fotheringham,et al.  A Case of Malignant Pleurisy , 1897, British medical journal.

[45]  M. Böhm,et al.  Low-grade albuminuria and cardiovascular risk , 2007, Clinical Research in Cardiology.

[46]  L Guize,et al.  Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. , 1999, Hypertension.